炎症与抑郁及焦虑的关联:症状特异性与潜在因果证据
研究基于英国生物银行147,478人和NESDA队列2,905人,分析循环CRP及IL-6与抑郁焦虑症状的关联。结果显示炎症主要与抑郁核心症状及躯体/神经植物性症状相关,焦虑关联较弱;孟德尔随机化提示IL-6活性可能因果性增加疲劳和睡眠问题风险。
要点
- CRP升高与抑郁心境、食欲改变、睡眠问题及疲劳相关,焦虑关联较弱。
- IL-6升高与快感缺失及睡眠增加相关,且与食欲减退相关。
- 遗传预测的IL-6活性升高与疲劳和睡眠问题风险增加相关。
核心结论
- 炎症与抑郁核心症状及躯体/神经植物性症状相关,与焦虑症状关联不一致。
- IL-6/IL-6R通路可能与抑郁存在因果联系。
研究设计与样本
- 数据来自英国生物银行147,478人和NESDA队列2,905人,测量循环CRP(两队列)和IL-6(NESDA)。
- 遗传工具来自已发表GWAS和UKB,采用孟德尔随机化分析。
- 抑郁和焦虑症状采用自评问卷评估。
主要发现
- CRP较高与抑郁心境(OR=1.06,95%CI=1.05-1.08)、食欲改变(OR=1.25,95%CI=1.23-1.28)、睡眠问题(OR=1.05,95%CI=1.04-1.06)和疲劳(OR=1.12,95%CI=1.11-1.14)相关。
- CRP较高与易激惹(OR=1.06,95%CI=1.05-1.08)和担忧控制(OR=1.03,95%CI=1.02-1.04)相关。
- NESDA中IL-6较高与快感缺失(OR=1.30,95%CI=1.12-1.52)相关。
- CRP较高与睡眠增加(OR=1.27,95%CI=1.13-1.43)及食欲增加(OR=1.21,95%CI=1.08-1.35)相关,IL-6较高与睡眠增加(OR=1.26,95%CI=1.07-1.49)及食欲减退(OR=1.45,95%CI=1.18-1.79)相关。
- 孟德尔随机化分析中,遗传预测IL-6活性较高与疲劳风险增加(estimate=0.25,SE=0.08)和睡眠问题风险增加(estimate=0.19,SE=0.07)相关。
临床怎么用
- 对抑郁患者可关注炎症相关症状群(疲劳、睡眠及食欲改变)以辅助评估。
- IL-6/IL-6R通路可能为抑郁症状的免疫治疗提供潜在靶点。
局限性
- 需实验研究进一步评估因果关系、机制及免疫治疗对抑郁症状的效用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We examined whether inflammation is uniformly associated with all depressive and anxiety symptoms, and whether these associations are potentially causal. Data was from 147,478 individuals from the UK Biobank (UKB) and 2,905 from the Netherlands Study of Depression and Anxiety (NESDA). Circulating C-reactive protein (CRP) was measured in both cohorts and interleukin-6 (IL-6) in NESDA. Genetic instruments for these proteins were obtained from published GWAS and UKB. Depressive and anxiety symptoms were assessed with self-report questionnaires. In NESDA, neurovegetative (appetite, sleep, psychomotor) symptoms were disaggregated as increased vs. decreased. In joint analyses, higher CRP was associated with depressive symptoms of depressed mood (OR = 1.06, 95% CI = 1.05-1.08), altered appetite (OR = 1.25, 95%CI = 1.23-1.28), sleep problems (OR = 1.05, 95%CI = 1.04-1.06), and fatigue (OR = 1.12, 95% CI = 1.11-1.14), and with anxiety symptoms of irritability (OR = 1.06, 95% CI = 1.05-1.08) and worrying control (OR = 1.03, 95% CI = 1.02-1.04). In NESDA, higher IL-6 was additionally associated with anhedonia (OR = 1.30, 95% CI = 1.12-1.52). Higher levels of both CRP (OR = 1.27, 95% CI = 1.13-1.43) and IL-6 (OR = 1.26, 95% CI = 1.07-1.49) were associated with increased sleep. Higher CRP was associated with increased appetite (OR = 1.21, 95% CI = 1.08-1.35) while higher IL-6 with decreased appetite (OR = 1.45, 95% CI = 1.18-1.79). In Mendelian Randomisation analyses, genetically predicted higher IL-6 activity was associated with increased risk of fatigue (estimate = 0.25, SE = 0.08) and sleep problems (estimate = 0.19, SE = 0.07). Inflammation was associated with core depressive symptoms of low mood and anhedonia and somatic/neurovegetative symptoms of fatigue, altered sleep and appetite changes. Less consistent associations were found for anxiety. The IL-6/IL-6R pathway could be causally linked to depression. Experimental studies are required to further evaluate causality, mechanisms, and usefulness of immunotherapies for depressive symptoms.
引用
- Milaneschi Y, Kappelmann N, Ye Z, et al. Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts. Mol Psychiatry. 2021. PMID: 34135474. doi:10.1038/s41380-021-01188-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。